NRAS and neoplasm: Because tumor samples reflect the average degree of all cell types present in the sample, including normal stromal cells, endothelial cells, and inflammatory cells, the finding that the NRAS mutation occurred in more than 50% of cells within the tumor suggests strongly that it is a clonal mutation in these tumors.